**Question:** FDA indications of inhaled NO is

A. Pulmonary hypertension
B. Congenital heart disease
C. Acute respiratory distress syndrome (ARDS)
D. Congenital heart block

**Core Concept:** Nitric oxide (NO) is a gaseous signaling molecule that plays a crucial role in regulating vasodilation, blood pressure, and immune response. Inhalation of NO, also known as inhaled nitric oxide (iNO), is used in the treatment of specific medical conditions in adults and children.

**Correct Answer: .**

**Why the Correct Answer is Right:** The Food and Drug Administration (FDA) has approved the use of inhaled nitric oxide for specific indications. These indications are primarily focused on improving oxygenation and reducing pulmonary hypertension. Inhaled NO directly targets pulmonary vasodilation, reducing pulmonary vascular resistance and improving oxygenation in patients with severe hypoxemia.

**Why Each Wrong Option is Incorrect:**

**A. Pulmonary hypertension:** While pulmonary hypertension is a clinical manifestation, it is not a specific indication for inhaled NO. Inhaled NO is used to treat severe pulmonary hypertension in certain conditions.

**B. Congenital heart disease:** Inhaled NO is not a primary treatment for congenital heart disease. It is used to improve oxygenation in specific cases, such as those with severe pulmonary hypertension.

**C. Acute respiratory distress syndrome (ARDS):** Inhaled NO is not universally recommended for treating ARDS. It is mainly used in specific situations with severe pulmonary hypertension, where conventional treatments have failed to improve oxygenation.

**D. Congenital heart block:** Inhaled NO is not approved by the FDA for congenital heart block. It is primarily used to treat pulmonary hypertension in specific conditions.

**Clinical Pearl:** Inhaled NO should be used cautiously and under the guidance of an experienced physician in the context of severe pulmonary hypertension and oxygenation impairment. It is not a general treatment for these conditions but rather a targeted therapy aimed at improving oxygenation and reducing pulmonary hypertension.